Company Revenue

The company grew in the mid-teens for the second quarter of 2023 and raised full-year guidance despite tougher comps in...

The company grew in the mid-single-digits on a pro forma basis for the second quarter of 2023 as it embarks...

The company grew in the double-digits for the second quarter of 2023 as it hit records for both total sales...

The company grew in the mid-single digits for 2Q23 as improving operational execution allowed it to leverage elevated orthopedic volumes....

The company grew nearly 40% in the second quarter of 2023 on the strength of its spine focus and lateral...

The company grew in the low single digits for the second quarter of 2023 but remains on track to achieve...

The company grew in the high single digits for the second quarter of 2023 on the strength of its joint...

The company grew 20% in the second quarter of 2023 despite supply constraints on some of its newest products....

The company declined in the high single digits in the second quarter of 2023, but found international success with differentiated...

The company grew in the mid-single-digits in the second quarter of 2023 as improved execution and new products offset macro...